Endocrine Abstracts

Introduction: Fahr’s disease is a rare, neurological disorder characterized by abnormal calcified deposits in basal ganglia. The clinical characteristics are various and usually appears such as disfunction of the affected areas. According to our knowledge, no case of Fahr’s disease together with pregnancy has been described in the literature until now. The objective of this case report was to describe the clinical course of this rare condition in pregnancy.<p cla...

Introduction: Pseudohypoparathyroidism is characterised by hypocalcaemia, hyperphosphataemia, increased serum parathyroid hormone values and insensitivity to the biological activity of parathyroid hormone. Pseudohypoparathyroidism is often associated with a characteristic phenotype known as Albright’s hereditary osteodystrophy. This case was reported in order to remind pseudohypoparathyroidism in patients with hypocalcemic seizures.Case report: We d...

Introduction: Serum IGF1 levels declined particularly with hyperglycemia in diabetic patients and lower IGF1 levels has been suggested to be associated with the development of diabetes. IGF1 levels appear to increase with the improvement in glycemic control in diabetic patients but do not reach normal levels. Also, it affected by gender; in this study we aimed to investigate effects of gender on IGF1 changes with basal insulin analogs.Methods: The serum ...

Aim: To evaluate the relationship between glycemic control and quality of life parameters in patients with poorly controlled type 2 diabetes.Methods: Fifty patients with poorly controlled (HbA1c 8–12%) type 2 diabetes included the study and were answered DQOL and SF-36 questionnaires to an assistant in internal medicine. HbA1c levels, age, gender, duration of diabetes, height, weight and waist–hip ratio measurements recorded at the same time.</...

Aim: To compare the effectiveness of insulin detemir when added to oral antidiabetic drug therapy as a single daily dose or twice daily.Method: Fifty patients with a diagnosis of type 2 diabetes receiving oral antidiabetic drug therapy and glycemic control did not provided were included the study. Insulin detemir was begun 0.1–0.2 U/kg daily dose, half of the patients started with a single daily dose and the other half with same dose twice daily. At...